NO20065196L - Terapeutisk kombinasjon for behandling av Alzheimers sykdom - Google Patents
Terapeutisk kombinasjon for behandling av Alzheimers sykdomInfo
- Publication number
- NO20065196L NO20065196L NO20065196A NO20065196A NO20065196L NO 20065196 L NO20065196 L NO 20065196L NO 20065196 A NO20065196 A NO 20065196A NO 20065196 A NO20065196 A NO 20065196A NO 20065196 L NO20065196 L NO 20065196L
- Authority
- NO
- Norway
- Prior art keywords
- disease
- alzheimer
- treatment
- therapeutic combination
- treating alzheimer
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title abstract 3
- 230000001225 therapeutic effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56214104P | 2004-04-14 | 2004-04-14 | |
| PCT/IB2005/000923 WO2005099823A1 (en) | 2004-04-14 | 2005-04-04 | Therapeutic combination for treatment of alzheimers disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20065196L true NO20065196L (no) | 2007-01-03 |
Family
ID=34963723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20065196A NO20065196L (no) | 2004-04-14 | 2006-11-13 | Terapeutisk kombinasjon for behandling av Alzheimers sykdom |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1737539A1 (https=) |
| JP (1) | JP2007532624A (https=) |
| KR (1) | KR20060133008A (https=) |
| CN (1) | CN1960781A (https=) |
| AU (1) | AU2005232447A1 (https=) |
| BR (1) | BRPI0509881A (https=) |
| CA (1) | CA2562069A1 (https=) |
| IL (1) | IL178120A0 (https=) |
| MX (1) | MXPA06011969A (https=) |
| NO (1) | NO20065196L (https=) |
| RU (1) | RU2006136361A (https=) |
| TW (1) | TW200533341A (https=) |
| WO (1) | WO2005099823A1 (https=) |
| ZA (1) | ZA200608239B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI432195B (zh) * | 2007-10-03 | 2014-04-01 | Kowa Co | 神經細胞死亡抑制劑 |
| US11129801B2 (en) * | 2016-02-11 | 2021-09-28 | Sigmathera Sas | Igmesine for use in the treatment of neurodegenerative diseases |
| EP3982956B1 (en) * | 2019-06-14 | 2024-06-12 | Joshua O. Atiba | Triple pharmaceutical composition for proteinaceous infection |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020028826A1 (en) * | 2000-06-15 | 2002-03-07 | Robl Jeffrey A. | HMG-CoA reductase inhibitors and method |
| IL164317A0 (en) * | 2002-04-02 | 2005-12-18 | Janssen Pharmaceutica Nv | Statin therapy for enhancing cognitive maintenance |
| WO2004034963A2 (en) * | 2002-05-17 | 2004-04-29 | Eisai Co., Ltd. | Methods and compositions using cholinesterase inhibitors |
| EP1585520A1 (en) * | 2002-12-24 | 2005-10-19 | Neurochem (International) Limited | Therapeutic formulations for the treatment of beta-amyloid related diseases |
| WO2004071431A2 (en) * | 2003-02-05 | 2004-08-26 | Myriad Genetics, Inc. | Method and composition for treating neurodegenerative disorders |
| CA2516990A1 (en) * | 2003-03-19 | 2004-09-30 | Ares Trading S.A. | Treatment of alzheimer's disease |
| US20050090449A1 (en) * | 2003-05-13 | 2005-04-28 | Boehringer Ingelheim International Gmbh | Novel statine derivatives for the treatment of Alzheimer's disease |
-
2005
- 2005-04-04 MX MXPA06011969A patent/MXPA06011969A/es unknown
- 2005-04-04 JP JP2007507862A patent/JP2007532624A/ja not_active Withdrawn
- 2005-04-04 CA CA002562069A patent/CA2562069A1/en not_active Abandoned
- 2005-04-04 RU RU2006136361/15A patent/RU2006136361A/ru not_active Application Discontinuation
- 2005-04-04 CN CNA2005800173902A patent/CN1960781A/zh active Pending
- 2005-04-04 AU AU2005232447A patent/AU2005232447A1/en not_active Abandoned
- 2005-04-04 EP EP05718393A patent/EP1737539A1/en not_active Withdrawn
- 2005-04-04 BR BRPI0509881-5A patent/BRPI0509881A/pt not_active IP Right Cessation
- 2005-04-04 WO PCT/IB2005/000923 patent/WO2005099823A1/en not_active Ceased
- 2005-04-04 KR KR1020067021174A patent/KR20060133008A/ko not_active Ceased
- 2005-04-13 TW TW094111657A patent/TW200533341A/zh unknown
-
2006
- 2006-09-14 IL IL178120A patent/IL178120A0/en unknown
- 2006-10-03 ZA ZA200608239A patent/ZA200608239B/en unknown
- 2006-11-13 NO NO20065196A patent/NO20065196L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL178120A0 (en) | 2006-12-31 |
| EP1737539A1 (en) | 2007-01-03 |
| BRPI0509881A (pt) | 2007-10-16 |
| ZA200608239B (en) | 2008-06-25 |
| CN1960781A (zh) | 2007-05-09 |
| AU2005232447A1 (en) | 2005-10-27 |
| TW200533341A (en) | 2005-10-16 |
| KR20060133008A (ko) | 2006-12-22 |
| JP2007532624A (ja) | 2007-11-15 |
| CA2562069A1 (en) | 2005-10-27 |
| RU2006136361A (ru) | 2008-04-20 |
| MXPA06011969A (es) | 2006-12-15 |
| WO2005099823A1 (en) | 2005-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200901373A1 (ru) | Аминогетероциклические соединения | |
| ATE475650T1 (de) | Positive allosterische chinolon-m1- rezeptormodulatoren | |
| ATE530544T1 (de) | Benzyl-substituierte positive allosterische chinolon-m1-rezeptormodulatoren | |
| FR16C0021I2 (fr) | Azetidines en tant qu'inhibiteurs de mek et leur utilisation pour le traitement des maladies proliferatives | |
| GB0318447D0 (en) | Therapeutic agents | |
| NO20055894L (no) | Fremgangsmater og blandinger for behandling av amyloidrelatertere sykdommer | |
| GB0223040D0 (en) | Therapeutic compounds | |
| EP1562897A4 (en) | PHENYL ACARBOXAMIDE AS A BETA SEKRETASE INHIBITOR FOR THE TREATMENT OF ALZHEIMER | |
| NO20084362L (no) | Difenylazetidinon derivater inneholdende kolesterol absorbsjonsinhibitor aktivitet | |
| MXPA05009595A (es) | Compuestos 7-amino-isoindolilo y sus usos farmaceuticos. | |
| PL2530083T3 (pl) | Inhibitory kinazy tyrozynowej brutona | |
| EA200900802A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
| NO20081421L (no) | Midler for hindring og behandling av forstyrrelser som involverer modulering av RYR-reseptorer | |
| ATE507204T1 (de) | Isoindolin-verbindungen und deren verwendungen | |
| NO20050851L (no) | Kaspase-inhibitorer og anvendelser derav | |
| NO20064325L (no) | Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes | |
| ATE409480T1 (de) | Pyrazoloä3,4-büpyridin-6-one als gsk-3 inhibitoren | |
| ATE371724T1 (de) | Behandlung neurodegenerativer krankheiten | |
| BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
| EA200801481A1 (ru) | 5-(арилсульфонил)пиразолопиперидины | |
| NO20044530L (no) | Fremgangsmate for behandling av kognitive forstyrrelser | |
| WO2007016338A3 (en) | Use of chk2 kinase inhibitors for cancer treatment | |
| EA200701181A1 (ru) | Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний | |
| NO20065196L (no) | Terapeutisk kombinasjon for behandling av Alzheimers sykdom | |
| TW200732304A (en) | Piperidine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |